on point 4): moving generics to China makes more sense if they are planning to use Canada facilities for something else...which would likely be Oxy and Regabatin .
we could have, over the next few months:
- china partnership - regabatin partnership - oxy settlement + partnership (still consider a Purdue partnership a possibility)
- 2 more ANDAs approval
enough for a normal biotech to make a 10x from here....I would be happe to be back @ 3.00